Literature DB >> 17910034

Regulation of C/EBPdelta-dependent transactivation by histone deacetylases in intestinal epithelial cells.

Naomie Turgeon1, Caroline Valiquette, Mylène Blais, Sophie Routhier, Ernest G Seidman, Claude Asselin.   

Abstract

The C/EBPdelta transcription factor is involved in the positive regulation of the intestinal epithelial cell acute phase response. C/EBPdelta regulation by histone deacetylases (HDACs) during the course of inflammation remains to be determined. Our aim was to examine the effect of HDACs on C/EBPdelta-dependent regulation of haptoglobin, an acute phase protein induced in intestinal epithelial cells in response to pro-inflammatory cytokines. HDAC1, HDAC3, and HDAC4 were expressed in intestinal epithelial cells, as determined by Western blot. GST pull-down assays showed specific HDAC1 interactions with the transcriptional activation and the b-ZIP C/EBPdelta domains, while the co-repressor mSin3A interacts with the C-terminal domain. Immunoprecipitation assays confirmed the interaction between HDAC1 and the N-terminal C/EBPdelta amino acid 36-164 domain. HDAC1 overexpression decreased C/EBPdelta transcriptional activity of the haptoglobin promoter, as assessed by transient transfection and luciferase assays. Chromatin immunoprecipitation analysis showed a displacement of HDAC1 from the haptoglobin promoter in response to inflammatory stimuli and an increased acetylation of histone H3 and H4. HDAC1 silencing by shRNA expression increased both basal and IL-1beta-induced haptoglobin mRNA levels in epithelial intestinal cells. Our results suggest that interactions between C/EBPs and HDAC1 negatively regulate C/EBPdelta-dependent haptoglobin expression in intestinal epithelial cells. 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17910034     DOI: 10.1002/jcb.21544

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

1.  The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis.

Authors:  Kuppusamy Balamurugan; Ju-Ming Wang; Hsin-Hwa Tsai; Shikha Sharan; Miriam Anver; Robert Leighty; Esta Sterneck
Journal:  EMBO J       Date:  2010-11-12       Impact factor: 11.598

2.  CCAAT/enhancer binding protein δ is a transcriptional repressor of α-synuclein.

Authors:  Tony Valente; Guido Dentesano; Mario Ezquerra; Ruben Fernandez-Santiago; Jonatan Martinez-Martin; Edurne Gallastegui; Carla Domuro; Yaroslau Compta; Maria J Martí; Oriol Bachs; Leonardo Márquez-Kisinousky; Marco Straccia; Carme Solà; Josep Saura
Journal:  Cell Death Differ       Date:  2019-06-17       Impact factor: 15.828

3.  Liver-enriched inhibitory protein (LIP) actively inhibits preadipocyte differentiation through histone deacetylase 1 (HDAC1).

Authors:  Houssein-Salem Abdou; Ella Atlas; Robert J G Haché
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

4.  Epithelial-mesenchymal transition during oncogenic transformation induced by hexavalent chromium involves reactive oxygen species-dependent mechanism in lung epithelial cells.

Authors:  Song-Ze Ding; Yu-Xiu Yang; Xiu-Ling Li; Audrey Michelli-Rivera; Shuang-Yin Han; Lei Wang; Poyil Pratheeshkumar; Xin Wang; Jian Lu; Yuan-Qin Yin; Amit Budhraja; Andrew J Hitron
Journal:  Toxicol Appl Pharmacol       Date:  2013-03-19       Impact factor: 4.219

Review 5.  The many faces of C/EBPδ and their relevance for inflammation and cancer.

Authors:  Kuppusamy Balamurugan; Esta Sterneck
Journal:  Int J Biol Sci       Date:  2013-09-20       Impact factor: 6.580

6.  The histone deacetylase Hdac1 regulates inflammatory signalling in intestinal epithelial cells.

Authors:  Alexis Gonneaud; Julie Moore Gagné; Naomie Turgeon; Claude Asselin
Journal:  J Inflamm (Lond)       Date:  2014-12-20       Impact factor: 4.981

Review 7.  Histone Deacetylases in the Inflamed Intestinal Epithelium-Promises of New Therapeutic Strategies.

Authors:  Lorenz Gerbeth; Rainer Glauben
Journal:  Front Med (Lausanne)       Date:  2021-03-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.